Literature DB >> 18540152

Preconditioning paradigms and pathways in the brain.

Karl B Shpargel1, Walid Jalabi, Yongming Jin, Alisher Dadabayev, Marc S Penn, Bruce D Trapp.   

Abstract

Preconditioning is a phenomenon in which the brain protects itself against future injury by adapting to low doses of noxious insults. Preconditioning stimuli include ischemia, low doses of endotoxin, hypoxia, hypothermia and hyperthermia, cortical spreading depression, anesthetics, and 3-nitropropionic acid, among others. Understanding of the mechanisms underlying preconditioning has been elusive, but NMDA receptor activation, nitric oxide, inflammatory cytokines, and suppression of the innate immune system appear to have a role. Elucidation of the endogenous cell survival pathways involved in preconditioning has significant clinical implications for preventing neuronal damage in susceptible patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540152     DOI: 10.3949/ccjm.75.suppl_2.s77

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  32 in total

Review 1.  Innate immunity in the central nervous system.

Authors:  Richard M Ransohoff; Melissa A Brown
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

2.  Enhanced hypoxic preconditioning by isoflurane: signaling gene expression and requirement of intracellular Ca2+ and inositol triphosphate receptors.

Authors:  Philip E Bickler; Christian S Fahlman
Journal:  Brain Res       Date:  2010-04-29       Impact factor: 3.252

Review 3.  The myeloid cells of the central nervous system parenchyma.

Authors:  Richard M Ransohoff; Astrid E Cardona
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

4.  A synergistic role of hyperthermic and pharmacological preconditioning to protect astrocytes against ischemia/reperfusion injury.

Authors:  Fang Du; Zhong-ming Qian; Li Zhu; Xiao Mei Wu; Wing Ho Yung; Ya Ke
Journal:  Neurochem Res       Date:  2010-12-03       Impact factor: 3.996

5.  Expression of signal transduction genes differs after hypoxic or isoflurane preconditioning of rat hippocampal slice cultures.

Authors:  Philip E Bickler; Christian S Fahlman
Journal:  Anesthesiology       Date:  2009-08       Impact factor: 7.892

6.  Cocaine-mediated microglial activation involves the ER stress-autophagy axis.

Authors:  Ming-Lei Guo; Ke Liao; Palsamy Periyasamy; Lu Yang; Yu Cai; Shannon E Callen; Shilpa Buch
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 7.  The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão's legacy.

Authors:  Jed A Hartings; C William Shuttleworth; Sergei A Kirov; Cenk Ayata; Jason M Hinzman; Brandon Foreman; R David Andrew; Martyn G Boutelle; K C Brennan; Andrew P Carlson; Markus A Dahlem; Christoph Drenckhahn; Christian Dohmen; Martin Fabricius; Eszter Farkas; Delphine Feuerstein; Rudolf Graf; Raimund Helbok; Martin Lauritzen; Sebastian Major; Ana I Oliveira-Ferreira; Frank Richter; Eric S Rosenthal; Oliver W Sakowitz; Renán Sánchez-Porras; Edgar Santos; Michael Schöll; Anthony J Strong; Anja Urbach; M Brandon Westover; Maren Kl Winkler; Otto W Witte; Johannes Woitzik; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

8.  Role of Phosphatidylinositol-3 Kinase Pathway in NMDA Preconditioning: Different Mechanisms for Seizures and Hippocampal Neuronal Degeneration Induced by Quinolinic Acid.

Authors:  Leandra C Constantino; Luisa B Binder; Samuel Vandresen-Filho; Giordano G Viola; Fabiana K Ludka; Mark W Lopes; Rodrigo B Leal; Carla I Tasca
Journal:  Neurotox Res       Date:  2018-04-20       Impact factor: 3.911

9.  Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4.

Authors:  Zhihong Chen; Walid Jalabi; Karl B Shpargel; Kenneth T Farabaugh; Ranjan Dutta; Xinghua Yin; Grahame J Kidd; Cornelia C Bergmann; Stephen A Stohlman; Bruce D Trapp
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

10.  Toll-like receptor 3 agonist Poly I:C protects against simulated cerebral ischemia in vitro and in vivo.

Authors:  Lin-na Pan; Wei Zhu; Cai Li; Xu-lin Xu; Lian-jun Guo; Qing Lu
Journal:  Acta Pharmacol Sin       Date:  2012-09-17       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.